Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
Hinge Bio to receive $10 million upfront and is eligible to receive…
POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks
POET's Optical Interposer platform integrates Semtech FiberEdge® technology to achieve cutting-edge sensitivity…
Wynn Unveils “Wynn Signature – 2025 Hypercar Exhibition” with Spectacular Fanfare to Elevate the Exhibition Experience
In celebration of Macao's iconic motorsport, this year's exhibition coincides with the…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET Â | Source: Nxera Pharma Tokyo, Japan and…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET Â | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
InboxAlly to Showcase Inbox-First Deliverability at LeadsCon Connect 2025 in Chicago
September 29, 2025 10:00 ET Â | Source: InboxAlly New York, NY, Sept.…
Department of Culture and Tourism – Abu Dhabi Announces Curatorial Team and Locations for Second Edition of Manar Abu Dhabi
Led by Artistic Director Khai Hori, the biannual light art exhibition returns…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET Â | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth
September 26, 2025 16:05 ET Â | Source: Silynxcom Ltd. Netanya, Israel, Sept.…
Maris-Tech Announces Financial Results for the Six Months Ended June 30, 2025
September 26, 2025 16:04 ET Â | Source: Maris-Tech Ltd. The company continues…